TCIM
COLL icon

TIAA CREF Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

TIAA CREF Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.21M Buy
79,728
+676
+0.9% +$10.8K ﹤0.01% 2229
2018
Q4 		$1.36M Buy
79,052
+2,014
+3% +$34.5K ﹤0.01% 2161
2018
Q3 		$1.14M Sell
77,038
-7,211
-9% -$128K ﹤0.01% 2370
2018
Q2 		$2.01M Buy
84,249
+24,429
+41% +$601K ﹤0.01% 2169
2018
Q1 		$1.53M Buy
59,820
+377
+0.6% +$8.98K ﹤0.01% 2245
2017
Q4 		$1.1M Buy
59,443
+281
+0.5% +$4.03K ﹤0.01% 2419
2017
Q3 		$621K Sell
59,162
-2,025
-3% -$22.3K ﹤0.01% 2733
2017
Q2 		$765K Buy
61,187
+18,691
+44% +$185K ﹤0.01% 2671
2017
Q1 		$428K Sell
42,496
-1,499
-3% -$22.3K ﹤0.01% 2837
2016
Q4 		$685K Buy
43,995
+1,234
+3% +$20.5K ﹤0.01% 2711
2016
Q3 		$824 Hold
42,761
– – ﹤0.01% 2634
2016
Q2 		$507K Buy
42,761
+19,275
+82% +$318K ﹤0.01% 2848
2016
Q1 		$426K Sell
23,486
-4,774
-17% -$86.8K ﹤0.01% 2830
2015
Q4 		$777K Buy
28,260
+2,498
+10% +$52.6K ﹤0.01% 2728
2015
Q3 		$570K Buy
25,762
+18,569
+258% +$336K ﹤0.01% 2845
2015
Q2 		$128K Buy
+7,193
New +$124K ﹤0.01% 3144

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

TIAA CREF Investment Management's COLL Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Collegium Pharmaceutical (COLL) stake by 0.86% in Q1 2019, buying an estimated $10.8K and bringing the position to 79,728 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

TIAA CREF Investment Management first reported a position in COLL in Q2 2015 and has held it in 16 quarters since. The position peaked at $2.01M in Q2 2018. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

  • TIAA CREF Investment Management held 79,728 shares of Collegium Pharmaceutical worth $1.21M as of Q1 2019.
  • TIAA CREF Investment Management bought 676 Collegium Pharmaceutical shares in Q1 2019, an estimated $10.8K.
  • Collegium Pharmaceutical made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2229 holding.
  • TIAA CREF Investment Management first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 16 quarters since.
  • TIAA CREF Investment Management's Collegium Pharmaceutical position peaked at $2.01M in Q2 2018.
  • 145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.